Home LiteratureArticle Details
PMID: 18056452 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Runx2 disruption promotes immortalization and confers resistance to oncogene-induced senescence in primary murine fibroblasts.

Cancer research ·Vol. 67 ·No. 23 ·2007-12-01 ·Pages 11263-71

Kilbey A, Blyth K, Wotton S, Terry A, Jenkins A, Bell M, Hanlon L, Cameron ER, Neil JC

Abstract

The Runx genes play paradoxical roles in cancer where they can function either as dominant oncogenes or tumor suppressors according to context. We now show that the ability to induce premature senescence in primary murine embryonic fibroblasts (MEF) is a common feature of all three Runx genes. However, ectopic Runx-induced senescence contrasts with Ras oncogene-induced senescence, as it occurs directly and lacks the hallmarks of proliferative stress. Moreover, a fundamental role for Runx function in the senescence program is indicated by the effects of Runx2 disruption, which renders MEFs prone to spontaneous immortalization and confers an early growth advantage that is resistant to stress-induced growth arrest. Runx2(-/-) cells are refractory to H-Ras(V12)-induced premature senescence, despite the activation of a cascade of growth inhibitors and senescence markers, and are permissive for oncogenic transformation. The aberrant behavior of Runx2(-/-) cells is associated with signaling defects and elevated expression of S-G(2)-M cyclins and their associated cyclin dependent kinase activities that may override the effects of growth inhibitory signals. Coupling of stress responses to the cell cycle represents a novel facet of Runx tumor suppressor function and provides a rationale for the lineage-specific effects of loss of Runx function in cancer.

MeSH Terms
3T3 Cells Animals Blotting, Western Cell Cycle Cell Transformation, Neoplastic Cellular Senescence Colony-Forming Units Assay Core Binding Factor Alpha 1 Subunit/genetics,physiology Cyclin-Dependent Kinases/metabolism Fibroblasts/physiology Genes, ras/physiology Immunoprecipitation Mice Mice, Nude
Chemicals
Core Binding Factor Alpha 1 Subunit Runx2 protein, mouse Cyclin-Dependent Kinases
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Kilbey Anna
Molecular Oncology Laboratory, Institute of Comparative Medicine, Faculty of Veterinary Medicine, University of Glasgow, Glasgow, United Kingdom. A.Kilbey@vet.gla.ac.uk
Blyth Karen
Wotton Sandy
Terry Anne
Jenkins Alma
Bell Margaret
Hanlon Linda
Cameron Ewan R
Neil James C
References (44)
44 references, click to expand
  1. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development.
    Cell. 1997 May 30;89(5):765-71 PMID: 9182764
  2. The common retroviral insertion locus Dsi1 maps 30 kilobases upstream of the P1 promoter of the murine Runx3/Cbfa3/Aml2 gene.
    J Virol. 2002 May;76(9):4364-9 PMID: 11932403
  3. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
    Mol Cell Biol. 2005 Sep;25(18):8097-107 PMID: 16135801
  4. Sensitivity to myc-induced apoptosis is retained in spontaneous and transplanted lymphomas of CD2-mycER mice.
    Oncogene. 2000 Feb 10;19(6):773-82 PMID: 10698495
  5. Molecular signature of oncogenic ras-induced senescence.
    Oncogene. 2004 Dec 9;23(57):9238-46 PMID: 15489886
  6. Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a.
    Mol Cell Biol. 2003 Jun;23(11):3859-71 PMID: 12748288
  7. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype.
    Blood. 2005 Jul 15;106(2):494-504 PMID: 15784726
  8. The RUNX genes: gain or loss of function in cancer.
    Nat Rev Cancer. 2005 May;5(5):376-87 PMID: 15864279
  9. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine.
    J Biol Chem. 1995 Mar 31;270(13):7420-6 PMID: 7535770
  10. Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene.
    Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8646-51 PMID: 9238031
  11. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.
    Nature. 2006 Nov 30;444(7119):638-42 PMID: 17136094
  12. Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts.
    Cancer Res. 2003 Sep 1;63(17):5357-62 PMID: 14500368
  13. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines.
    J Cell Biol. 1963 May;17:299-313 PMID: 13985244
  14. A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation.
    Genes Dev. 2006 Jan 15;20(2):236-52 PMID: 16418486
  15. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence.
    Mol Cell Biol. 2002 May;22(10):3389-403 PMID: 11971971
  16. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
    Leukemia. 2006 Apr;20(4):635-44 PMID: 16467864
  17. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.
    Cell. 1997 Mar 7;88(5):593-602 PMID: 9054499
  18. RUNX1 transformation of primary embryonic fibroblasts is revealed in the absence of p53.
    Oncogene. 2004 Jul 15;23(32):5476-86 PMID: 15133495
  19. BRAFE600-associated senescence-like cell cycle arrest of human naevi.
    Nature. 2005 Aug 4;436(7051):720-4 PMID: 16079850
  20. Isolation of the Drosophila segmentation gene runt and analysis of its expression during embryogenesis.
    Genes Dev. 1988 Sep;2(9):1179-93 PMID: 2847961
  21. Molecular dissection of formation of senescence-associated heterochromatin foci.
    Mol Cell Biol. 2007 Mar;27(6):2343-58 PMID: 17242207
  22. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.
    Nat Med. 2002 Jul;8(7):743-50 PMID: 12091906
  23. RUNX transcription factors as key targets of TGF-beta superfamily signaling.
    Curr Opin Genet Dev. 2003 Feb;13(1):43-7 PMID: 12573434
  24. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia.
    J Biol Chem. 2000 Jan 7;275(1):651-6 PMID: 10617663
  25. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter.
    Mol Cell Biol. 2002 Nov;22(22):7982-92 PMID: 12391164
  26. Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo.
    Cancer Res. 2006 Feb 15;66(4):2195-201 PMID: 16489021
  27. Oncogenes and senescence: breaking down in the fast lane.
    Genes Dev. 2007 Jan 1;21(1):1-5 PMID: 17210783
  28. Cooperation of activating Ras/rtk signal transduction pathway mutations and inactivating myeloid differentiation gene mutations in M0 AML: a study of 45 patients.
    Leukemia. 2006 Mar;20(3):433-6 PMID: 16424869
  29. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.
    Nature. 2005 Aug 4;436(7051):725-30 PMID: 16079851
  30. Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma.
    Cancer Res. 2002 Dec 15;62(24):7181-5 PMID: 12499254
  31. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
    Mol Cell Biol. 2000 Apr;20(7):2529-42 PMID: 10713176
  32. Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging.
    Oncogene. 2001 Jan 18;20(3):295-302 PMID: 11313958
  33. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence.
    Nat Cell Biol. 2002 Feb;4(2):148-53 PMID: 11812999
  34. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.
    Nature. 2006 Nov 30;444(7119):633-7 PMID: 17136093
  35. RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells.
    Surgery. 2004 Aug;136(2):310-6 PMID: 15300196
  36. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.
    Nucleic Acids Res. 1990 Jun 25;18(12):3587-96 PMID: 2194165
  37. Cellular senescence: mitotic clock or culture shock?
    Cell. 2000 Aug 18;102(4):407-10 PMID: 10966103
  38. A negative feedback signaling network underlies oncogene-induced senescence.
    Cancer Cell. 2006 Dec;10(6):459-72 PMID: 17157787
  39. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions.
    Genes Dev. 2001 Feb 15;15(4):398-403 PMID: 11230148
  40. Oncogene-induced senescence pathways weave an intricate tapestry.
    Cell. 2007 Jan 26;128(2):233-4 PMID: 17254959
  41. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence.
    Cell. 2003 Jun 13;113(6):703-16 PMID: 12809602
  42. Coordinate regulation of cell growth and differentiation by TGF-beta superfamily and Runx proteins.
    Oncogene. 2004 May 24;23(24):4232-7 PMID: 15156178
  43. Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads.
    Cell. 2003 May 2;113(3):301-14 PMID: 12732139
  44. SWI/SNF chromatin remodeling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation.
    J Cell Biochem. 2005 Mar 1;94(4):720-30 PMID: 15565649
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
1538-7445
Published
2007-12-01
Pages
11263-71
Language
English
Region
United States
NLM ID
2984705R
PMCID
PMC2562449
Subset
IM
Grants
Cancer Research UK · A5605 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com